COSENTINO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 28.560
EU - Europa 16.706
AS - Asia 10.758
SA - Sud America 1.300
Continente sconosciuto - Info sul continente non disponibili 310
AF - Africa 235
OC - Oceania 28
Totale 57.897
Nazione #
US - Stati Uniti d'America 28.174
IT - Italia 7.664
SG - Singapore 3.445
UA - Ucraina 2.703
CN - Cina 2.416
SE - Svezia 1.649
TR - Turchia 1.523
VN - Vietnam 1.466
BR - Brasile 1.120
HK - Hong Kong 1.111
DE - Germania 896
FI - Finlandia 793
IE - Irlanda 734
GB - Regno Unito 697
FR - Francia 633
RU - Federazione Russa 386
IN - India 217
MX - Messico 167
CA - Canada 159
BD - Bangladesh 157
JP - Giappone 117
PL - Polonia 77
AR - Argentina 74
NL - Olanda 68
NG - Nigeria 67
ZA - Sudafrica 65
ES - Italia 63
BE - Belgio 59
CZ - Repubblica Ceca 59
CH - Svizzera 51
IQ - Iraq 48
EU - Europa 31
AT - Austria 30
LT - Lituania 27
PK - Pakistan 27
UZ - Uzbekistan 26
EC - Ecuador 25
MA - Marocco 22
ID - Indonesia 21
CO - Colombia 20
AE - Emirati Arabi Uniti 19
AU - Australia 19
KE - Kenya 18
DZ - Algeria 17
JO - Giordania 17
CL - Cile 16
PH - Filippine 16
IL - Israele 15
MY - Malesia 15
NP - Nepal 15
PY - Paraguay 15
RO - Romania 15
SA - Arabia Saudita 14
EG - Egitto 12
JM - Giamaica 12
HU - Ungheria 11
VE - Venezuela 11
BG - Bulgaria 10
CR - Costa Rica 10
KR - Corea 10
TN - Tunisia 10
PT - Portogallo 9
GR - Grecia 8
NZ - Nuova Zelanda 8
RS - Serbia 8
SM - San Marino 8
AZ - Azerbaigian 7
DK - Danimarca 7
HN - Honduras 7
LB - Libano 6
NI - Nicaragua 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
ET - Etiopia 5
KZ - Kazakistan 5
LU - Lussemburgo 5
MD - Moldavia 5
NO - Norvegia 5
OM - Oman 5
TH - Thailandia 5
UY - Uruguay 5
GT - Guatemala 4
GY - Guiana 4
KG - Kirghizistan 4
PA - Panama 4
PE - Perù 4
AF - Afghanistan, Repubblica islamica di 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GA - Gabon 3
GD - Grenada 3
HR - Croazia 3
KW - Kuwait 3
SR - Suriname 3
TL - Timor Orientale 3
TW - Taiwan 3
Totale 57.570
Città #
Milan 4.946
San Jose 2.318
Fairfield 2.129
Chandler 2.106
Jacksonville 2.082
Ashburn 2.015
Singapore 1.973
Woodbridge 1.696
Dallas 1.593
Hong Kong 1.099
Ann Arbor 1.077
Houston 1.039
Wilmington 922
Seattle 894
Cambridge 749
Izmir 725
Dublin 724
Princeton 718
Council Bluffs 691
Dearborn 655
Nyköping 610
Beijing 604
The Dalles 495
Dong Ket 445
Boardman 409
Rome 407
Chicago 384
Como 361
Lauterbourg 347
New York 294
San Mateo 286
Los Angeles 280
Ho Chi Minh City 220
Santa Clara 212
Helsinki 191
Hanoi 173
San Diego 169
Orem 150
London 147
Munich 137
Ogden 137
Tokyo 117
Mexico City 113
São Paulo 110
Guangzhou 91
Frankfurt am Main 87
Hefei 84
Chennai 83
Washington 83
Des Moines 72
Warsaw 70
Atlanta 68
Düsseldorf 67
Abuja 65
Denver 65
Phoenix 63
Montreal 60
Nanjing 59
Shanghai 58
Buffalo 56
Kunming 53
Brooklyn 52
Norwalk 52
Varese 51
Verona 51
Brno 50
Brussels 48
Johannesburg 47
Redwood City 47
Stockholm 47
San Francisco 44
Hangzhou 43
Manchester 43
Poplar 43
Amsterdam 39
Ponte Lambro 39
Zhengzhou 39
Rio de Janeiro 38
Berlin 36
Tianjin 36
Columbus 35
Toronto 35
Da Nang 33
Jinan 33
Mountain View 33
Boston 32
Brasília 29
Pune 28
Shenyang 27
Ankara 26
Mumbai 25
Belo Horizonte 24
Auburn Hills 23
Haiphong 23
Miami 23
Biên Hòa 21
Fuzhou 20
Paris 20
Philadelphia 20
Shenzhen 20
Totale 39.508
Nome #
1-year statin treatment reverts the pro-inflammatory cytokine interleukin-8 release of primed neutrophils in dyslipidemic subjects 1.171
Coronavirus Disease-19 Vaccines Best Reflect Effective Pharmaceuticals 449
Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. 379
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 275
Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia 274
Adrenergic modulation of migration, CD11b and CD18 expression, ROS and interleukin-8 production by human polymorphonuclear leukocytes 261
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 252
Adrenergic regulation of innate immunity: a review 250
Calcium homeostasis is dysregulated in parkinsonian patients with l-DOPA-induced dyskinesias 249
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment 248
Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease 240
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study 236
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 232
Adrenergic modulation of immune cells: an update 231
An unusual systemic reaction associated with topical salicylic acid in a paediatric patient 229
Isoflavone content and estrogenic activity of different batches of red clover (Trifolium pratense L.) extracts: An in vitro study in MCF-7 cells 229
Acetylcholine detection by a modified HPLC-ED method improves the assessment of cholinergic function in the myenteric plexus of the guinea-pig colon. 228
Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin. 228
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 226
Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis 226
Expression of dopaminergic receptors on human CD4+ T lymphocytes: flow cytometric analysis of naive and memory subsets and relevance for the neuroimmunology of neurodegenerative disease 224
Peripheral CD4+CD25+ Regulatory T-cell Frequency is Increased in High-Cardiovascular-Risk Subjects and is not Modified after 1-month Statin Treatment: a Longitudinal Study. 221
Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease 221
7-hydroxymatairesinol potassium acetate (Hmr/LignanTM) from Norway spruce (Picea abies) knots and its active metabolite enterolactone exert estrogenic effects in the in MCF-7 cell model. 219
Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon. 219
Characterization of human leukocyte-HUVEC adhesion: Effect of cell preparation methods 219
The essential oil of bergamot stimulates reactive oxygen species production in human polymorphonuclear leukocytes 219
Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study 218
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients 218
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines 215
Association between the circadian course of endogenous noradrenaline and the hematopoietic cell cycle in mouse bone marrow. 214
Dopaminergic D-1-like receptor-dependent inhibition of tyrosine hydroxylase mRNA expression and catecholamine production in human lymphocytes 214
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients 213
Estrogenic activity of 7-hydroxymatairesinol potassium acetate (HMR/lignantrade mark) from Norway spruce (Picea abies) knots and of its active metabolite enterolactone in MCF-7 cells. 212
Adrenergic mechanisms in multiple sclerosis: the neuro-immune connection? 212
Dopaminergic inhibition of human neutrophils is exerted through D1-like receptors and affected by bacterial infection 210
Effects of a novel cyclic RGD peptidomimetic on cell proliferation, migration and angiogenic activity in human endothelial cells 210
Scanning electron microscopy examination of endothelium morphology in human carotid plaques 207
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 204
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 204
Improved solubility and increased biological activity of NeoSol (TM) RCL40, a novel Red Clover Isoflavone Aglycones extract preparation 203
Are CYP1A2*1F and *1C associated with clozapine tolerability? A preliminary investigation 203
Synthesis, Characterization, and Biological Evaluation of a Dual-Action Ligand Targeting αvβ3 Integrin and VEGF Receptors 202
Production of proinflammatory mediators by human neutrophils during long-term culture 202
cAMP levels in lymphocytes and CD4+ regulatory T-cell functions are affected by dopamine receptor gene polymorphisms 202
Dopaminergic receptors and adrenoceptors in circulating lymphocytes as putative biomarkers for the early onset and progression of multiple sclerosis 201
Clopidogrel pharmacogenetics: Associations between genotype and stent thrombosis risk in patients with stent placement 200
Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat 196
Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence 195
Levodopa-induced neutropenia 195
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 195
Dopaminergic modulation of oxidative stress and apoptosis in human peripheral blood lymphocytes: Evidence for a D1-like receptor-dependent protective effect 194
Calcium channel blockers and gastrointestinal motility: basic and clinical aspects 194
Two patients with COMT inhibitor–induced hepatic dysfunction and UGT1A9 genetic polymorphism 193
Gene expression of adhesion molecules in endothelial cells from patients with peripheral arterial disease is reduced after surgical revascularization and pharmacological treatment 193
Effects of a commercial product containing guaraná on psychological well-being, anxiety and mood: a single-blind, placebo-controlled study in healthy subjects 193
Use of herbal remedies by multiple sclerosis patients: a nation-wide survey in Italy 193
Modulation of enteric cholinergic neurons by hetero- and autoreceptors: cooperation among inhibitory inputs 192
Immunomodulatory activity of the lignan 7-hydroxymatairesinol potassium acetate (HMR/LignanTM) extracted from the heartwood of norway spruce (Picea abies) 192
Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. 190
Dopaminergic receptor D5 mRNA expression is increased in circulating lymphocytes of Tourette syndrome patients 190
Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes. 188
Endogenous catecholamine synthesis, metabolism storage, and uptake in human peripheral blood mononuclear cells 188
Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils 188
Effect of the lipopolysaccharide antagonist Planktothrix sp. FP1 cyanobacterial extract on human polymorphonuclear leukocytes. 188
Increased expression of dopamine receptors in synovial fibroblasts from patients with rheumatoid arthritis: inhibitory effects of dopamine on interleukin-8 and interleukin-6 187
Levels of mRNA for dopaminergic receptor D₅ in circulating lymphocytes may be associated with subsequent response to interferon-β in patients with multiple sclerosis 187
Carbamazepine affects neutrophil function through an action on peripheral benzodiazepine receptors. 186
Diazepam-binding inhibitor-derived peptides induce intracellular calcium changes and modulate human neutrophil function 185
The Second Insubria Autumn School on Neuroimmune Pharmacology: Repurposing Established Drugs for Novel Indications 184
Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks? 183
Effect of chronic sympathetic denervation or chronic naltrexone treatment on the sensitivity of enteric cholinergic neurons to opioid receptor agonists. 182
HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines 181
Dopamine, T cells and multiple sclerosis (MS) 181
Assessment of catecholamine content and metabolism in human pheripheral blood leukocytes subpopulation and leukemia cell lines 180
Adverse drug events in emergency department population: a prospective Italian study. 180
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 180
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 180
A rapid and sensitive method to assay endogenous acetylcholine overflow from myenteric neurons by means of HPLC and electrochemical detection. 179
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR) 179
Thyroid hormone regulation of cell migration and oxidative metabolism in polymorphonuclear leukocytes: clinical evidence in thyroidectomized subjects on thyroxine replacement therapy. 178
Atorvastatin treatment influences polymorphonuclear leukocyte function: a longitudinal study. 178
Diazepam stimulates migration and phagocytosis of human neutrophils: Possible contribution of peripheral-type benzodiazepine receptors and intracellular calcium 177
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 177
“Patterns” di deposito di calico-fosforo nelle placche carotidee nell’uomo. 177
Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. 177
Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson’s disease. The effect of dopaminergic treatment 177
Studi sul ruolo di diversi sistemi recettoriali nella modulazione della liberazione di neurotrasmettitori dal plesso mienterico. 175
Effects of atorvastatin treatment on the modulation of leukocyte function in patients undergoing peripheral vascular intervention: a longitudinal study 175
Simvastatin treatment in subjects at high cardiovascular risk modulates AT(1)R expression on circulating monocytes and T lymphocytes 175
Angiotensin II Type1 and type2 receptor expression in circulating monocytes of diabetic patients over 3-month rosuvastatin treatment 175
Functional interaction between presynaptic receptors modulating transmitter release in the Autonomic Nervous System. 174
Effects of carbamazepine on human PMN function: possible role of peripheral benzodiazepine receptors. 174
Treatment with simvastatin modifies AT1R expression and function in polymorphonuclear leukocyte of high cardiovascular risk subjects: a longitudinal study 173
Adverse reaction to COMT inhibitors in Parkinson's disease patients: possible association with the UGTIA9 gene haplotype 173
Thyroid hormone and thyrotropin regulate intracellular free calcium concentrations in human polymorphonuclear leukocytes: in vivo and in vitro studies 173
Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. 172
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 171
β 2 -Adrenoceptors inhibit neutrophil extracellular traps in human polymorphonuclear leukocytes 170
Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin 170
Totale 21.501
Categoria #
all - tutte 227.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.843


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.689 0 456 383 578 198 186 152 203 194 514 314 511
2022/20235.478 499 372 456 636 353 1.164 29 741 732 175 209 112
2023/20247.971 1.238 1.189 1.278 1.519 1.497 586 42 170 216 66 49 121
2024/20255.474 64 103 1.054 156 157 279 284 446 524 455 508 1.444
2025/202614.797 1.097 1.033 1.248 1.890 1.450 881 2.925 925 1.436 970 575 367
2026/20271.163 390 773 0 0 0 0 0 0 0 0 0 0
Totale 57.897